Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEK
10501
iShares Technology Opportunities Active ETF
TEK
$41.5M
| $246K | ﹤0.01% |
+11,015
| New | +$280K |
|
10502
CALL
News Corp Class B
NWS
$18.7B
| $246K | ﹤0.01% |
+8,100
| New | +$256K |
|
|
PPTA
10503
PUT
Perpetua Resources
PPTA
$3.14B
| $246K | ﹤0.01% |
23,000
-400
| -2% | -$4.29K |
|
|
LCG
10504
DELISTED
Sterling Capital Focus Equity ETF
LCG
| $246K | ﹤0.01% |
+8,848
| New | +$270K |
|
10505
FT Vest International Equity Moderate Buffer ETF December
YDEC
$168M
| $245K | ﹤0.01% |
10,353
-228
| -2% | -$5.35K |
|
10506
PUT
Rocket Pharmaceuticals
RCKT
$424M
| $245K | ﹤0.01% |
36,800
+25,100
| +215% | +$248K |
|
|
RAPP
10507
Rapport Therapeutics
RAPP
$2.34B
| $245K | ﹤0.01% |
+24,471
| New | +$318K |
|
10508
FT Vest US Equity Deep Buffer ETF December
DDEC
$439M
| $245K | ﹤0.01% |
6,270
-32,233
| -84% | -$1.3M |
|
|
FSP
10509
Franklin Street Properties
FSP
$42.2M
| $245K | ﹤0.01% |
137,838
+70,586
| +105% | +$130K |
|
10510
CALL
Workhorse Group
WKHS
$33.6M
| $245K | ﹤0.01% |
11,108
+9,736
| +710% | +$687K |
|
|
IMVP
10511
CALL
Invesco India ETF
IMVP
$106M
| $245K | ﹤0.01% |
+9,800
| New | +$241K |
|
10512
Precigen
PGEN
$2.49B
| $245K | ﹤0.01% |
164,458
-540,435
| -77% | -$851K |
|
10513
PUT
Clarivate
CLVT
$1.29B
| $245K | ﹤0.01% |
62,300
+24,200
| +64% | +$115K |
|
|
RDNW
10514
RideNow Group
RDNW
$221M
| $245K | ﹤0.01% |
86,785
+8,521
| +11% | +$35.1K |
|
10515
Neuropace
NPCE
$495M
| $245K | ﹤0.01% |
19,909
+7,295
| +58% | +$91.3K |
|
10516
Karat Packaging
KRT
$979M
| $245K | ﹤0.01% |
+9,203
| New | +$274K |
|
10517
Quad
QUAD
$519M
| $244K | ﹤0.01% |
44,808
+22,760
| +103% | +$145K |
|
10518
ProShares UltraShort Industrials
SIJ
$6.09M
| $244K | ﹤0.01% |
+7,209
| New | +$232K |
|
10519
Universal Logistics Holdings
ULH
$515M
| $244K | ﹤0.01% |
9,295
+4,205
| +83% | +$144K |
|
10520
Arq
ARQ
$94.3M
| $244K | ﹤0.01% |
58,481
+4,557
| +8% | +$25.9K |
|
10521
PUT
DXC Technology
DXC
$1.79B
| $244K | ﹤0.01% |
14,300
+4,200
| +42% | +$81.6K |
|
10522
CALL
iShares MSCI Australia ETF
EWA
$1.34B
| $244K | ﹤0.01% |
10,400
-1,500
| -13% | -$36.4K |
|
10523
Inogen
INGN
$146M
| $244K | ﹤0.01% |
34,187
-41,325
| -55% | -$390K |
|
10524
Atara Biotherapeutics
ATRA
$92.3M
| $244K | ﹤0.01% |
+41,014
| New | +$358K |
|
10525
Canterbury Park Holding Corp
CPHC
$82.5M
| $244K | ﹤0.01% |
13,348
+130
| +1% | +$2.63K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.